Advertisement

Journal of Bone and Mineral Metabolism

, Volume 6, Issue 3, pp 12–17 | Cite as

Can serum osteocalcin levels predict bone turnover in patients with osteoporosis?

  • Tohru Tsunenari
  • Mutsumi Takenaka
  • Masaaki Fukase
  • Takuo Fujita
Original Articles
  • 65 Downloads

Abstract

The assessment of bone metabolism by biochemical markers remains difficult problem. Serum osteocalcin, synthesized in bone cells, is now becoming a sensitive indicator of bone turnover in patients with metabolic bone diseases. We measured serum osteocalcin levels by radioimmunoassay in 18 patients with osteoporosis and examined whether they reflect bone formation, resorption or both. We found that serum osteocalcin levels in biopsy-identified osteoporotics were widely ranged (1.8 – 18.8 ng/ml). Tetracycline double labeling method exibited two types of labeling pattern in the iliac bone, that is double labeled or no double labeled (impaired labeled) pattern. Serum concentrations of osteocalcin in patients with double labeling were significantly higher than those with impaired labeling (11.2±4.0 vs 4.1 ±2.1 ng/ml, P<0.01). Furthermore, serum osteocalcin levels showed a significantly positive linear correlation with the parameters reflecting bone formation, but not with bone resorption. These data indicate that serum osteocalcin levels reflect bone formation in osteoporotics and thereby could be a useful indicator of osteoblastic function in osteoporosis.

Key Words

Osteocalcin Bone Histomorphometry Osteoporosis Osteoblast Bone remodeling 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Whyte, M.P., Bergfeld, M.A., Murphy, W.A., Avioli, L.V. and Teitelbaum, S.L.: Postmenopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients. Am.J.Med. 72: 193–202, 1982PubMedGoogle Scholar
  2. 2.
    Price, P.A., Parthemore, J.G. and Deftos, L.J.: New biochemical marker for bone metabolism. J. Clin. Invest. 66:878–883, 1980PubMedGoogle Scholar
  3. 3.
    Hauschka, P.V., Lian, J.B. and Gallop, P.M.: Direct identification of the calcium binding amino acid.γ-carboxyglutamate, in mineralized tissue. Proc. Natl. Acad. Sci. USA. 72: 3925–3929, 1975PubMedGoogle Scholar
  4. 4.
    Price, P.A., Otsuka, A.S., Poser, J.W., Kristaponis, J., and Raman, N.: Characterization of aγ-carboxyglutamic acid-containing protein from bone. Pro c.Natl.Acad.Sci. USA. 73: 447–451, 1976Google Scholar
  5. 5.
    Lian, J.B. and Friedman, P.A.: The vitamin K-dependentγ-carboxyglutamic acid by bone microsomes. J.Biol.Chem. 253:6623–6626, 1978PubMedGoogle Scholar
  6. 6.
    Nishimoto, S.K. and Price, P.A.: Secretion of the vitamin K dependent protein of bone by rat osteosarcoma cells. J.Biol.Chem. 255:6579–6583, 1980PubMedGoogle Scholar
  7. 7.
    Gallop, P.M., Lian, J.B., and Hauschka, P.V.: Carboxylated calcium binding protein and vitamin K. N.Engl.J.Med. 302:1460–1466, 1980PubMedGoogle Scholar
  8. 8.
    Price, P.A., Williamson, M.K., and Lothringer, J.W.: Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J.Biol.Chem. 256: 12760–12766, 1981PubMedGoogle Scholar
  9. 9.
    Price, P.A. and Baukal, S.A.: 1,25-dihydroxy vitamin D increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J.Biol.Chem. 255: 11660–11663, 1980PubMedGoogle Scholar
  10. 10.
    Nordin, B.E.C., Aaron, J., Speed, R., and Crilly, R.G.: Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis. Lancet II: 277–279, 1981Google Scholar
  11. 11.
    Delmas, P.D., Wahner, H.W., Mann, K.G. and Riggs, B.L.: Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone gla protein. J.Lab.Clin.Med. 102:470–476, 1983PubMedGoogle Scholar
  12. 12.
    Epstein, S., Poser, J., McClintok, R., Johnston, C.C., Bryce, G., and Hui, S. Differences in serum bone gla protein with age and sex. Lancet I: 307–310, 1984Google Scholar
  13. 13.
    Gundberg, C.M., Lian, J.B., Gallop, P.M., and Steinberg, J.J.: Urinaryγ-carboxyglutamic acid and serum osteocalcin as bone markers: Studies in osteoporosis and Paget's disease. J.Clin.Endocrinol.Metab. 57: 1221–1225, 1983PubMedGoogle Scholar
  14. 14.
    Gundberg, C.M., Lian, J.B., and Gallop, P.M.: Measurement ofγ-carboxyglutamate and circulating osteocalcin in normal children and adults. Clin.Chim.Acta. 128:1–8, 1983CrossRefPubMedGoogle Scholar
  15. 15.
    Otawara, Y., Hosoya, N., Kasai, H., Okuyama, N., and Moriuchi, S.: Purification and characterization of calcium-binding protein containingγ-carboxyglutamic acid from rat bone. J.Nutr.Sci.Vitaminol. 26:209–219, 1980PubMedGoogle Scholar
  16. 16.
    Brown, J.P., Delmas, P.D., Malaval, L., Edouard, C., Chapuy, M.C., and Meunier, P.J.: Serum bone gla-protein; A specific marker for bone formation in postmenopausal osteoporosis. Lancet I: 1091–1093, 1984Google Scholar
  17. 17.
    Uzawa, T., Morita, K., Hori, M., Yoshizawa, M., Noda, S., Amizawa, S., Inoue, J., and Takahashi, H.: Correlation between serum BGP and bone turnover in canine. J.Bone.Mineral.Metab. 3 Supple:47 (Abstract in Japanese), 1985Google Scholar
  18. 18.
    Gundberg, C.M., Cole, D.E.C., Lian, J.B., Reade, T.M., and Gallop, P.M.: Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxy vitamin D. J.Clin.Endocrinol.Metab. 56: 1063–1067, 1983PubMedGoogle Scholar
  19. 19.
    Deftos, L.J., Parthemore, J.G., and Price, P.A.: Changes in plasma bone gla protein during treatment of bone disease. Calcif.Tissue.Int. 34: 121–124, 1982PubMedGoogle Scholar
  20. 20.
    Delmas, P.D., Demiaux, B., Malaval, L., Chapuy, M.C., Edouard, C., and Meunier, P.J.: Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry. J.Clin.Invest. 77:985–991, 1986PubMedGoogle Scholar
  21. 21.
    Brown, J.P., Delmas, P.D., Arlot, M., and Meunier, P.J.: Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis. J.Clin.Endocrinol.Metab. 64:954–959, 1987PubMedGoogle Scholar

Copyright information

© Japanese Society of Bone Metabolism Research 1988

Authors and Affiliations

  • Tohru Tsunenari
    • 1
  • Mutsumi Takenaka
    • 1
  • Masaaki Fukase
    • 1
  • Takuo Fujita
    • 1
  1. 1.Third Division, Department of MedicineKobe University School of MedicineKobeJapan

Personalised recommendations